RRC ID 51843
Author Sumi H, Inazuka M, Hashimoto K, Ishikawa T, Yoshida S, Yabuki M.
Title T-3256336, a novel and orally available small molecule IAP antagonist, induced tumor cell death via induction of systemic TNF alpha production.
Journal Biochem Biophys Res Commun
Abstract Inhibitors of apoptosis proteins (IAPs) are a family of antiapoptotic regulators that have attracted attention as potential targets for cancer therapeutics. Although recent studies have revealed that small-molecule IAP antagonists induce tumor selective cell death in an autocrine tumor necrosis factor (TNF)α-dependent manner, the single-agent efficacy of IAP antagonists is restricted to a small subset of cancer cells. In this study, we showed that the single-agent activity of T-3256336 was limited to a few cancer cell lines in vitro, and these cell lines were defined by relatively high levels of TNFα mRNA expression. However, some other cancer cells, including PANC-1 cells, become drastically sensitive to T-3256336 when costimulated with exogenous TNFα. In PANC-1 mouse xenograft models, the administration of T-3256336 increased levels of several cytokines including TNFα and lead to tumor regression as a single agent, which was attenuated by the neutralization of circulating mouse TNFα with an antibody. These results suggest dual roles of IAP antagonists, increase systemic cytokines including TNFα, and sensitization of tumors to IAP antagonist-induced death.
Volume 479(2)
Pages 179-185
Published 2016-10-14
DOI 10.1016/j.bbrc.2016.09.019
PII S0006-291X(16)31470-X
PMID 27608596
MeSH Administration, Oral Animals Blotting, Western Cell Line Cell Line, Tumor Cell Survival / drug effects Cytokines / blood Enzyme-Linked Immunosorbent Assay Gene Expression Regulation, Neoplastic / drug effects HL-60 Cells Humans Inhibitor of Apoptosis Proteins / antagonists & inhibitors* Inhibitor of Apoptosis Proteins / metabolism MCF-7 Cells Mice Neoplasms / drug therapy* Neoplasms / genetics Neoplasms / metabolism Oligopeptides / administration & dosage Oligopeptides / pharmacology* Pyrazines / administration & dosage Pyrazines / pharmacology* Reverse Transcriptase Polymerase Chain Reaction Tumor Burden / drug effects Tumor Necrosis Factor-alpha / blood Tumor Necrosis Factor-alpha / genetics* Tumor Necrosis Factor-alpha / pharmacology Xenograft Model Antitumor Assays
IF 2.705
Times Cited 1
Human and Animal Cells PC-14(RCB0446)